205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1819281062762643456 |
|---|---|
| author | Burcu Yigit Xavier Michelet Darrian Moskowitz Marc Van Dijk Antoine Tanne |
| author_facet | Burcu Yigit Xavier Michelet Darrian Moskowitz Marc Van Dijk Antoine Tanne |
| author_sort | Burcu Yigit |
| collection | DOAJ |
| first_indexed | 2024-12-24T00:53:43Z |
| format | Article |
| id | doaj.art-b58f704714ef439db8bb7989d7e49c93 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-24T00:53:43Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-b58f704714ef439db8bb7989d7e49c932022-12-21T17:23:31ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.205205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft modelsBurcu Yigit0Xavier Michelet1Darrian Moskowitz2Marc Van Dijk3Antoine Tanne4Agenus, Lexington, MA, USAAgenus, Lexington, MA, USAAgenus, Lexington, MA, USA4AgenTus Therapeutics, Inc., Cambridge, UK2Agenus, Lexington, MA, USA |
| spellingShingle | Burcu Yigit Xavier Michelet Darrian Moskowitz Marc Van Dijk Antoine Tanne 205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models Journal for ImmunoTherapy of Cancer |
| title | 205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models |
| title_full | 205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models |
| title_fullStr | 205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models |
| title_full_unstemmed | 205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models |
| title_short | 205 AgenT-797, a native allogeneic ‘off-the-shelf’ iNKT cell therapy product shows anti-tumor activity in preclinical xenograft models |
| title_sort | 205 agent 797 a native allogeneic off the shelf inkt cell therapy product shows anti tumor activity in preclinical xenograft models |
| work_keys_str_mv | AT burcuyigit 205agent797anativeallogeneicofftheshelfinktcelltherapyproductshowsantitumoractivityinpreclinicalxenograftmodels AT xaviermichelet 205agent797anativeallogeneicofftheshelfinktcelltherapyproductshowsantitumoractivityinpreclinicalxenograftmodels AT darrianmoskowitz 205agent797anativeallogeneicofftheshelfinktcelltherapyproductshowsantitumoractivityinpreclinicalxenograftmodels AT marcvandijk 205agent797anativeallogeneicofftheshelfinktcelltherapyproductshowsantitumoractivityinpreclinicalxenograftmodels AT antoinetanne 205agent797anativeallogeneicofftheshelfinktcelltherapyproductshowsantitumoractivityinpreclinicalxenograftmodels |